doi: 10.3389/fendo.2025.1683419 Received 12 August 2025 Revised 04 December 2025 Accepted 30 December 2025 Published 23 January 2026 Volume 16 - 2025 Edited by Claudia Lagranha, Federal University of Pernambuco, Brazil Reviewed by Lei Zhao, China Medical University, China Michihiro Takahashi, Takahashi Psychiatric Clinic, Japan Sundararajan Mahalingam, University of Nebraska Omaha, United States Rodolfo Nunes, Federal University of Ceara, Brazil Updates Copyright 2026 Doval-Caballero, Ferreira-Hermosillo, Eugenio-Ponce, Garca-Senz, Ibarra-Salce, Tenorio-Rojo, Luna-Avila, Gete-Palacios, Prez-Hernndez, Rojas-Miln, Lpez-Cruz and Mndez-Hernndez
Enter Nonsurgical Weight Loss Procedures Now, if youre not a fan of needles, or just want something with fewer side effects, lets talk about nonsurgical options
Pataer A, Fanale MA, Roth JA, Swisher SG , Hunt KK
Park, J., Lee, H., Sikiric, P., & Hahm, K
A population average cannot predict an individual response, some people tolerate one of these drugs and not the other, and no test exists that forecasts which one you are
GLP-1 receptor agonists are a class of prescription medications originally developed for the management of type 2 diabetes and subsequently studied for use in weight management in eligible adults
